Works matching IS 00071048 AND DT 2017 AND VI 179 AND IP 1


Results: 24
    1
    2
    3
    4
    6
    7
    8
    9
    10
    11
    12
    13

    Natural history of amyloidosis isolated to fat and bone marrow aspirate.

    Published in:
    British Journal of Haematology, 2017, v. 179, n. 1, p. 170, doi. 10.1111/bjh.14205
    By:
    • Chakraborty, Rajshekhar;
    • Gertz, Morie A.;
    • Dispenzieri, Angela;
    • Gonsalves, Wilson I.;
    • Zeldenrust, Steven R.;
    • Russell, Stephen J.;
    • Go, Ronald S.;
    • Kapoor, Prashant;
    • Rajkumar, Vincent S.;
    • Hayman, Suzanne R.;
    • Hwa, Yi L.;
    • Lacy, Martha Q.;
    • Kyle, Robert A.;
    • Leung, Nelson;
    • Kumar, Shaji K.
    Publication type:
    Article
    14

    Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial.

    Published in:
    British Journal of Haematology, 2017, v. 179, n. 1, p. 66, doi. 10.1111/bjh.14821
    By:
    • San‐Miguel, Jesús F.;
    • Hungria, Vania T. M.;
    • Yoon, Sung‐Soo;
    • Beksac, Meral;
    • Dimopoulos, Meletios A.;
    • Elghandour, Ashraf;
    • Jedrzejczak, Wieslaw W.;
    • Guenther, Andreas;
    • Na Nakorn, Thanyaphong;
    • Siritanaratkul, Noppadol;
    • Schlossman, Robert L.;
    • Hou, Jian;
    • Moreau, Philippe;
    • Lonial, Sagar;
    • Lee, Jae‐Hoon;
    • Einsele, Hermann;
    • Salwender, Hans;
    • Sopala, Monika;
    • Redhu, Suman;
    • Paul, Sofia
    Publication type:
    Article
    15
    16

    Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient-related factors and measuring from time of first red blood cell transfusion dependence: an MDS- CAN analysis.

    Published in:
    British Journal of Haematology, 2017, v. 179, n. 1, p. 83, doi. 10.1111/bjh.14825
    By:
    • Leitch, Heather A.;
    • Parmar, Ambica;
    • Wells, Richard A.;
    • Chodirker, Lisa;
    • Zhu, Nancy;
    • Nevill, Thomas J.;
    • Yee, Karen W. L.;
    • Leber, Brian;
    • Keating, Mary‐Margaret;
    • Sabloff, Mitchell;
    • St. Hilaire, Eve;
    • Kumar, Rajat;
    • Delage, Robert;
    • Geddes, Michelle;
    • Storring, John M.;
    • Kew, Andrea;
    • Shamy, April;
    • Elemary, Mohamed;
    • Lenis, Martha;
    • Mamedov, Alexandre
    Publication type:
    Article
    17

    Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia.

    Published in:
    British Journal of Haematology, 2017, v. 179, n. 1, p. 98, doi. 10.1111/bjh.14826
    By:
    • Paludo, Jonas;
    • Abeykoon, Jithma P.;
    • Kumar, Shaji;
    • Shreders, Amanda;
    • Ailawadhi, Sikander;
    • Gertz, Morie A.;
    • Kourelis, Taxiarchis;
    • King, Rebecca L.;
    • Reeder, Craig B.;
    • Leung, Nelson;
    • Kyle, Robert A.;
    • Buadi, Francis K.;
    • Habermann, Thomas M.;
    • Dingli, David;
    • Witzig, Thomas E.;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Go, Ronald S.;
    • Lin, Yi;
    • Gonsalves, Wilson I.
    Publication type:
    Article
    18
    19
    20

    Issue Information.

    Published in:
    British Journal of Haematology, 2017, v. 179, n. 1, p. 1, doi. 10.1111/bjh.14366
    Publication type:
    Article
    21
    22
    23
    24